search
Back to results

Preoperative Exercise for Patients Undergoing Complex Cancer Surgery (PRE-HIIT)

Primary Purpose

Postoperative Complications, Physical Activity, Surgery--Complications

Status
Recruiting
Phase
Not Applicable
Locations
Ireland
Study Type
Interventional
Intervention
Control
Exercise - HIIT Intervention
Sponsored by
University of Dublin, Trinity College
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Postoperative Complications focused on measuring Prehabilitation, Exercise, Surgery

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Patients who are scheduled for either oesophagectomy (2-stage or 3-stage) or major lung resection for the management of primary oesophageal or lung cancer.
  • Date of surgery ≥ 2 weeks from baseline assessment
  • Ability to provide written informed consent
  • Absence of significant co-morbidities, including metastatic disease, which may adversely impact postoperative outcome
  • Successful completion of a medically supervised cardiopulmonary exercise test
  • Patients with oesophageal cancer scheduled for multimodal therapy including preoperative chemo(radio)therapy and oesophagectomy will be recruited and tested prior to treatment commencement.

Exclusion Criteria:

  • The American Thoracic Society/American College of Chest Physicians (ATS/ACCP) absolute contraindications for exercise testing will be applied.
  • Patients undergoing video assisted lobectomy for early lung cancer will be excluded.

Sites / Locations

  • University of Dublin, Trinity CollegeRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Experimental

Arm Label

Control

HIIT Intervention

Arm Description

This arm will complete a standard prehabilitation intervention.

This group will complete a pre-operative high intensity interval training programme.

Outcomes

Primary Outcome Measures

Change in Cardiorespiratory Fitness
Cardiorespiratory fitness will be determined by Cardiopulmonary Exercise Test (CPET)

Secondary Outcome Measures

Clavien-Dindo Scale
Measurement of the most severe complication that occurs in the postoperative period. The ordinal scale is divided into seven grades (Grade I-V, two sub-groups each for Grade III and IV), ranging from Grade I, which considers any deviation from normal, to Grade V, which describes death of the patient.
Change in the Post-Operative Morbidity Score (POMS)
The POMS is a nine-domain tool that prospectively describes and records in-hospital postoperative complications following major surgery.
The Comprehensive Classification Index (CCI)
This is a summary of overall morbidity including the type, number and severity of each complication experienced during the postoperative period.
Change in Pulmonary function
Pulmonary function will be measured as the first step of the CPET. This will be used to determine forced vital capacity (FVC), forced expiratory volume at 1s (FEV1) and the ratio of FEV1/FVC.
Change in Maximum Inspiratory pressure
PImax will measured using a PowerBreathe K-series portable respiratory pressure metre. Patients will be measured at residual volume during a forceful inspiratory manoeuvre while resting in a seated position.
Change in Muscle strength
Quadriceps muscle strength will be measured by 1 repetition maximum (1RM) in kg's using a horizontal leg extension. The 1RM is defined as the highest load that can be lifted through full range of movement at one time.
Change in Self reported physical activity: International Physical Activity Questionnaire (IPAQ)
This questionnaire evaluates activity in metabolic equivalent (MET)-hours per week over the previous seven days. The questionnaire also quantifies average weekend and weekday sitting time. The questionnaire also quantifies average weekend and weekday sitting time.
Change in Self reported functional recovery
Participants will rate their recovery as 0%, 25%, 50%, 75% or 100% according to standardised descriptors.
Change in Functional Performance
This will be measured using the Short Physical Performance Battery (SPPB). This measure combines the results of gait speed, chair stand and balance tests. A score lower than 10 indicates one or more mobility limitations.
Change in Quality of Life
Quality of Life will be determined by the European Organisation for Research and Treatment of Cancer Core Quality of Life Questionnaire (EORTC-QLQ-C30). Scores are reported on a linear scale from 0-100. A high score in a functional scale indicates greater function. A high score in a symptom scale indicates greater symptom burden.
Change in Quality of Life (Specific to Lung Cancer)
For Oesophago-gastric Cancer Patients Quality of Life will be further assessed with the European Organisation for Research and Treatment of Cancer Oesophago-gastric Cancer Subscale the EORTC QLQ-LC 13. Scores are reported on a linear scale from 0-100. A high score in a functional scale indicates greater function. A high score in a symptom scale indicates greater symptom burden.
Change in Quality of Life (Specific to Oesophageal Cancer)
For Oesophago-gastric Cancer Patients Quality of Life will be further assessed with the European Organisation for Research and Treatment of Cancer Oesophago-gastric Cancer Subscales the EORTC QLQ-OES18 and QLQ-OES25. Scores are reported on a linear scale from 0-100. A high score in a functional scale indicates greater function. A high score in a symptom scale indicates greater symptom burden.
Cost Effectiveness
The costs of the program will be set against the effects on HRQOL
Qualitative Approach
Focus groups and interviews will be carried out with participants to gain their perspectives of the impact of the program on physical and mental well-being.

Full Information

First Posted
May 17, 2019
Last Updated
April 5, 2022
Sponsor
University of Dublin, Trinity College
Collaborators
Health Research Board, Ireland, Irish Cancer Society
search

1. Study Identification

Unique Protocol Identification Number
NCT03978325
Brief Title
Preoperative Exercise for Patients Undergoing Complex Cancer Surgery
Acronym
PRE-HIIT
Official Title
Preoperative Exercise to Improve Fitness in Patients Undergoing Complex Surgery for Cancer of the Lung or Oesophagus
Study Type
Interventional

2. Study Status

Record Verification Date
April 2022
Overall Recruitment Status
Recruiting
Study Start Date
July 1, 2021 (Actual)
Primary Completion Date
February 28, 2023 (Anticipated)
Study Completion Date
February 28, 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Dublin, Trinity College
Collaborators
Health Research Board, Ireland, Irish Cancer Society

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Treatment for people with cancer of the lung or the oesophagus (food-pipe) often involves surgery. This surgery is complex and there is a high risk that patients will develop severe complications afterwards, leading to a longer hospital stay and higher hospital costs, and impacting greatly on recovery and quality of life. If patients' lungs and heart can be optimised before surgery, then recovery may be improved. While fitness can be improved by exercise, the lead-in time to surgery following a cancer diagnosis is often very short, and research is needed to examine what types of exercise might be most effective at increasing fitness over a short period. This project will investigate if high intensity interval training (HIIT) can increase fitness levels in people scheduled for surgery for cancer of the oesophagus or the lungs. HIIT alternates between periods of high intensity exercise, cycling on a stationary bike, followed by a period of more relaxed exercise. This approach is known to improve fitness but has not previously been investigated in patients awaiting complex cancer surgery. Groups will be compared for changes in pre-surgery fitness levels, any complications they may experience after surgery, general physical recovery after surgery and the cost of care after surgery. The investigators anticipate that patients who undergo HIIT before surgery will have less complications and better recovery after surgery, a significantly improved quality of life, and lower costs of care.
Detailed Description
Patients with cancer of the lung or oesophagus, undergoing curative treatment, usually require a thoracotomy and a complex oncological resection. These surgeries carry a risk of major morbidity and mortality, and risk assessment, preoperative optimisation, and enhanced recovery after surgery (ERAS) pathways are modern approaches to optimise outcomes. Pre-operative fitness is an established predictor of postoperative outcome, accordingly targeting pre-operative fitness through exercise prehabilitation has logical appeal. Exercise prehabilitation is challenging to implement however due to the short opportunity for intervention between diagnosis and surgery. Therefore, individually prescribed, intensive exercise training protocols which convey clinically meaningful improvements in cardiopulmonary fitness over a short period need to be investigated. This project will examine the influence of exercise prehabilitation on physiological outcomes and postoperative recovery, evaluation of health economics, the impact of the programme on hospital costs. This study will take the form of a randomised controlled trial aimed primarily at improving pre-operative fitness with high intensity interval training (HIIT). HIIT prescribes aerobic exercise which alternates between periods of high intensity training and active recovery. This form of exercise training stimulates greater improvements in cardiopulmonary fitness over short periods compared to continuous aerobic training and therefore may be ideally suited to exercise prehabilitation. The primary outcome, cardiopulmonary fitness, will be measured by cardiopulmonary exercise testing and explored further using a suite of pulmonary and physical performance measures. Secondary outcomes will examine the impact of individually prescribed HIIT on postoperative outcome, postoperative physical recovery, restoration of pre-treatment fitness levels and both acute and sub-acute hospital costs. The investigators anticipate that this mode of exercise prehabilitation will attenuate postoperative risk and improve postoperative recovery, thus improving patient quality of life and having considerable economic benefits for the healthcare system.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Postoperative Complications, Physical Activity, Surgery--Complications
Keywords
Prehabilitation, Exercise, Surgery

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
InvestigatorOutcomes Assessor
Masking Description
Double
Allocation
Randomized
Enrollment
78 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Control
Arm Type
Active Comparator
Arm Description
This arm will complete a standard prehabilitation intervention.
Arm Title
HIIT Intervention
Arm Type
Experimental
Arm Description
This group will complete a pre-operative high intensity interval training programme.
Intervention Type
Other
Intervention Name(s)
Control
Intervention Description
The control group will receive standard pre-operative care. This involves standard pre-operative advice and a moderate intensity preoperative exercise programme.
Intervention Type
Other
Intervention Name(s)
Exercise - HIIT Intervention
Intervention Description
The HIIT intervention will take the form of a supervised programme, completed for at least two weeks, up to 5 days per week preoperatively. The HIIT intervention will be performed on a cycle ergometer. Exercise sessions will be individually supervised and scheduled at a time of convenience for each participant. Each exercise session will last 40 minutes and will include warm-up, exercise training and cool-down components. Lactate threshold, measured during the baseline CPT, will be used to determine the exercise intensity. The training protocol will prescribe 15 second intervals of exercise and passive recovery. The highest resistance reached during the baseline CPET (measured in watts) will be recorded as the peak power output (PPO). During training, participants will undergo a 5-minute warm-up at 50% PPO, followed by up to 30 minutes of HIIT with intervals of 15 seconds at 100% PPO with 15 second recovery periods at 0 watts.
Primary Outcome Measure Information:
Title
Change in Cardiorespiratory Fitness
Description
Cardiorespiratory fitness will be determined by Cardiopulmonary Exercise Test (CPET)
Time Frame
At diagnosis (Dx), baseline (T0), immediately post-intervention (T1)
Secondary Outcome Measure Information:
Title
Clavien-Dindo Scale
Description
Measurement of the most severe complication that occurs in the postoperative period. The ordinal scale is divided into seven grades (Grade I-V, two sub-groups each for Grade III and IV), ranging from Grade I, which considers any deviation from normal, to Grade V, which describes death of the patient.
Time Frame
At hospital discharge (approximately 7-14 days postoperatively)
Title
Change in the Post-Operative Morbidity Score (POMS)
Description
The POMS is a nine-domain tool that prospectively describes and records in-hospital postoperative complications following major surgery.
Time Frame
On postoperative day 5, postoperative day 7 and at hospital discharge (approximately 7-14 days postoperatively)
Title
The Comprehensive Classification Index (CCI)
Description
This is a summary of overall morbidity including the type, number and severity of each complication experienced during the postoperative period.
Time Frame
At hospital discharge (approximately 7-14 days postoperatively)
Title
Change in Pulmonary function
Description
Pulmonary function will be measured as the first step of the CPET. This will be used to determine forced vital capacity (FVC), forced expiratory volume at 1s (FEV1) and the ratio of FEV1/FVC.
Time Frame
At diagnosis (Dx), baseline (T0), immediately post-intervention (T1)
Title
Change in Maximum Inspiratory pressure
Description
PImax will measured using a PowerBreathe K-series portable respiratory pressure metre. Patients will be measured at residual volume during a forceful inspiratory manoeuvre while resting in a seated position.
Time Frame
At diagnosis (Dx), baseline (T0), immediately post-intervention (T1)
Title
Change in Muscle strength
Description
Quadriceps muscle strength will be measured by 1 repetition maximum (1RM) in kg's using a horizontal leg extension. The 1RM is defined as the highest load that can be lifted through full range of movement at one time.
Time Frame
At diagnosis (Dx), baseline (T0), immediately post-intervention (T1)
Title
Change in Self reported physical activity: International Physical Activity Questionnaire (IPAQ)
Description
This questionnaire evaluates activity in metabolic equivalent (MET)-hours per week over the previous seven days. The questionnaire also quantifies average weekend and weekday sitting time. The questionnaire also quantifies average weekend and weekday sitting time.
Time Frame
At diagnosis (Dx), baseline (T0), immediately post-intervention (T1) as well as post-operative day 30
Title
Change in Self reported functional recovery
Description
Participants will rate their recovery as 0%, 25%, 50%, 75% or 100% according to standardised descriptors.
Time Frame
At post-operative day 30
Title
Change in Functional Performance
Description
This will be measured using the Short Physical Performance Battery (SPPB). This measure combines the results of gait speed, chair stand and balance tests. A score lower than 10 indicates one or more mobility limitations.
Time Frame
At diagnosis (Dx), baseline (T0), immediately post-intervention (T1)
Title
Change in Quality of Life
Description
Quality of Life will be determined by the European Organisation for Research and Treatment of Cancer Core Quality of Life Questionnaire (EORTC-QLQ-C30). Scores are reported on a linear scale from 0-100. A high score in a functional scale indicates greater function. A high score in a symptom scale indicates greater symptom burden.
Time Frame
At diagnosis (Dx), baseline (T0), immediately post-intervention (T1) and on post-operative day 30.
Title
Change in Quality of Life (Specific to Lung Cancer)
Description
For Oesophago-gastric Cancer Patients Quality of Life will be further assessed with the European Organisation for Research and Treatment of Cancer Oesophago-gastric Cancer Subscale the EORTC QLQ-LC 13. Scores are reported on a linear scale from 0-100. A high score in a functional scale indicates greater function. A high score in a symptom scale indicates greater symptom burden.
Time Frame
At diagnosis (Dx), baseline (T0), immediately post-intervention (T1) and on post-operative day 30.
Title
Change in Quality of Life (Specific to Oesophageal Cancer)
Description
For Oesophago-gastric Cancer Patients Quality of Life will be further assessed with the European Organisation for Research and Treatment of Cancer Oesophago-gastric Cancer Subscales the EORTC QLQ-OES18 and QLQ-OES25. Scores are reported on a linear scale from 0-100. A high score in a functional scale indicates greater function. A high score in a symptom scale indicates greater symptom burden.
Time Frame
At diagnosis (Dx), baseline (T0), immediately post-intervention (T1) and on post-operative day 30.
Title
Cost Effectiveness
Description
The costs of the program will be set against the effects on HRQOL
Time Frame
At routine post-operative clinic visits at 6 weeks and 3 months postoperatively.
Title
Qualitative Approach
Description
Focus groups and interviews will be carried out with participants to gain their perspectives of the impact of the program on physical and mental well-being.
Time Frame
Immediately after the programme intervention (T1)

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patients who are scheduled for either oesophagectomy (2-stage or 3-stage) or major lung resection for the management of primary oesophageal or lung cancer. Date of surgery ≥ 2 weeks from baseline assessment Ability to provide written informed consent Absence of significant co-morbidities, including metastatic disease, which may adversely impact postoperative outcome Successful completion of a medically supervised cardiopulmonary exercise test Patients with oesophageal cancer scheduled for multimodal therapy including preoperative chemo(radio)therapy and oesophagectomy will be recruited and tested prior to treatment commencement. Exclusion Criteria: The American Thoracic Society/American College of Chest Physicians (ATS/ACCP) absolute contraindications for exercise testing will be applied. Patients undergoing video assisted lobectomy for early lung cancer will be excluded.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Gráinne Sheill, PhD
Phone
01-8964809
Email
sheillg@tcd.ie
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Juliette Hussey, PhD
Organizational Affiliation
University of Dublin, Trinity College
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Dublin, Trinity College
City
Dublin
Country
Ireland
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Grainne Sheill
First Name & Middle Initial & Last Name & Degree
Juliette Hussey, PhD
First Name & Middle Initial & Last Name & Degree
Emer Guinan, PhD

12. IPD Sharing Statement

Citations:
PubMed Identifier
32293334
Citation
Sheill G, Guinan E, O'Neill L, Normand C, Doyle SL, Moore S, Newell J, McDermott G, Ryan R, Reynolds JV, Hussey J. Preoperative exercise to improve fitness in patients undergoing complex surgery for cancer of the lung or oesophagus (PRE-HIIT): protocol for a randomized controlled trial. BMC Cancer. 2020 Apr 15;20(1):321. doi: 10.1186/s12885-020-06795-4.
Results Reference
derived

Learn more about this trial

Preoperative Exercise for Patients Undergoing Complex Cancer Surgery

We'll reach out to this number within 24 hrs